跳至主要内容
临床试验/CTRI/2020/08/027117
CTRI/2020/08/027117招募中2 期

Focal Radiotherapy Plus Low-Dose Craniospinal Irradiation Followed By Adjuvant Chemotherapy in WNT Subgroup Medulloblastoma(FOR-WNT 2 STUDY) - (FOR-WNT 2 STUDY)

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age more than 3 years and less than 16 years.
  • Newly diagnosed WNT pathway medulloblastoma.
  • Post-surgery residual disease less than 1.5 cm2 on post-operative MRI brain.
  • No evidence of metastatic disease in the brain, spine or cerebral spinal fluid (CSF) assessed by MRI of the brain/spine and lumbar puncture for CSF cytology.
  • Fit for initiation of adjuvant treatment within 6-weeks of surgery

排除标准

  • Age Less than 3 and more than 16 years.
  • Molecular subgroup other than WNT pathway.
  • Post-surgery residual disease more than 1.5cm2 on post-operative imaging.
  • Evidence of any metastatic disease in the brain, spine or CSF.
  • Previous history of radiotherapy or chemotherapy prior to study enrollment.
  • Not fit for initiation of adjuvant treatment within 6 weeks of surgery.
  • Not willing for consent/assent.

研究者

相似试验